Advertisement

Topics

R-Biopharm Inc. Company Profile

16:48 EDT 17th August 2018 | BioPortfolio

R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the development, production and marketing of two different product lines.1) Enzyme immunoassays for the detection of residues in food and feed
This product line contains test systems for the rapid screening for mycotoxins, hormones and anabolics, antibiotics, vitamins, food allergens and some other parameters
2) Enzyme immunoassays for the detection of human infectious diseases
The product line contains test systems in the field of stool diagnostics, infectious disease, serology and allergy testing
All products, agri/food diagnostics as well as the clinical diagnostics, are distributed world-wide under the trademarks RIDASCREEN and RIDA via an international distributor network or through own daughter companies like in the US (R-Biopharm Inc.), in the UK (R-Biopharm Rhône Ltd), in France (R-Biopharm France) and in Italy (R-Biopharm Italia).
Since November 1996 the quality management of R-Biopharm is certified according to DIN EN ISO 9001 and DIN EN 46001 (medical products). Certification according to the Quality Management Standard ISO 13485 (Medical product) took place in 2003.
Since January 1st 2000 R-Biopharm is the world-wide exclusive distributor for the Boehringer Mannheim Roche enzymatic tests.

Location

7950 Old US 27 South
Marshall
Michigan
49068
United States of America

Contact

Phone: 1 269 7 89 30 33
Fax: 1 269 7 89 30 70
Email: webmaster@r-biopharm.com


News Articles [78 Associated News Articles listed on BioPortfolio]

Win a FREE TICKET to BioPharm America 2018

If you haven’t heard of BioPharm America™, here’s what you need to know: BioPharm America is an international partnering conference with a focus on the life science industry. The conferen...

Janssen to acquire BeneVir Biopharm for up to $1bn

Johnson & Johnson subsidiary Janssen Biotech has signed a definitive agreement to buy biotechnology company BeneVir Biopharm for a total...Read More... The post Janssen to acquire BeneVir Biopharm...

Johnson & Johnson Acquire BeneVir Biopharm

NewsJanssen will gain Benevir Biopharm's oncolytic immunotherapy platform in the acquisition.

Tot Biopharm launches mAb manufacturing plant in China

Tot Biopharm has opened its second monoclonal antibody (mAb) production plant in Suzhou Industrial Park, China.

#jobs #lifescience BioPharm/BioTech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BioPharm/BioTech .MA-Cambridge, BioPharma/BioTech BIOPHARMA/BIOTECH Amgen, In...

TC BioPharm, Scotia Biologics partner for cancer drug R&D

Biotechnology company TC BioPharm and Scotia Biologics agreed to work together to develop therapies for cancer and major vira -More- 

J&J Janssen arm to Buy Benevir Biopharm

BeneVir Biopharm, a privately-held biotechnology company in the life science portfolio of the HC2 holding, will be bought by Janssen Biotech, a subsidiary of Johnson & Johnson under a recently sig...

Janssen Biotech to buy BeneVir Biopharm in $1bn deal

Janssen Biotech has agreed to acquire US-based BeneVir Biopharm, a biopharmaceutical company focused on developing oncolytic immunotherapies for cancer, in a deal worth $1.04bn.

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers" Eur. J. Pharm. Biopharm. 127 (2018) 432-442.

Staphylococcus aureus colonization and risk of surgical site infection in children undergoing clean elective surgery: A cohort study.

Staphylococcus aureus persistently colonizes the skin and nasopharynx of approximately 20% to 30% of individuals, with the highest rates in younger children. To avoid clinical problems for carriers an...

Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.

Doxorubicin (DOX) has been extensively used to treat a wide range of cancers in free and nanotized form. Nanotization of Doxorubicin (DOX) has alleviated its toxicity and efflux-mediated resistance. H...

Assessment of antimicrobial drug administration and antimicrobial residues in food animals in Enugu State, Nigeria.

Imprudent administration of antimicrobial drugs in food-producing animals can facilitate the development and spread of antimicrobial-resistant organisms and also enhance the occurrence of antimicrobia...

Clinical Trials [0 Results]

None

Companies [33 Associated Companies listed on BioPortfolio]

BioPharm Services US

BioPharm Services was first registered in 1998 and now employs more than 10 people in 2 offices in the US and UK. The company provides a broad spectrum of consultancy services covering all aspects of ...

R-Biopharm Inc.

R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the develo...

TTY Biopharm

TTY Biopharm stands to innovate the industry,emerge anew from the ashes of self-kindled flames, and accept multi challenges, encourage enterprising ventures, and share its knowledge and information.

Biopharm

Biopharm is a multinational company founded in 1995 by a group of scientists and business executives with the vision of developing innovative natural nutraceuticals that are backed by solid scientific...

BioPharm Insight

BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousa...

More Information about "R-Biopharm Inc." on BioPortfolio

We have published hundreds of R-Biopharm Inc. news stories on BioPortfolio along with dozens of R-Biopharm Inc. Clinical Trials and PubMed Articles about R-Biopharm Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of R-Biopharm Inc. Companies in our database. You can also find out about relevant R-Biopharm Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record